ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Distant metastasis is the principal cause of mortality for breast cancer patients. Targeting specific mutations that have been acquired during the evolution process of advanced breast cancer is a potential means of enhancing the clinical efficacy of treatment strategies. In metastatic breast cancer,...
Saved in:
Main Authors: | Xuan Cheng, Jian-Xiong Zhao, Feng Dong, Xu-Chen Cao |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cb7b9d2bd5ac409393c064b6b03f2372 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence
by: Shou Liu, et al.
Published: (2021) -
Identification of de novo mutations for ARID1B haploinsufficiency associated with Coffin–Siris syndrome 1 in three Chinese families via array-CGH and whole exome sequencing
by: Guanting Lu, et al.
Published: (2021) -
Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription
by: Seraina Blümli, et al.
Published: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
by: Mohamad Adham Salkeni, et al.
Published: (2017) -
The Genomic Landscape of the Fungus-Specific SWI/SNF Complex Subunit, Snf6, in <named-content content-type="genus-species">Candida albicans</named-content>
by: Faiza Tebbji, et al.
Published: (2017)